Delivery Order SPE2DE24D0013-SPE2D625F2TNR

The U.S. Defense Department's Medical Supply Chain awarded a $11,404.80 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) testing supplies. The contract was awarded on September 8, 2025, with an ultimate completion date of September 19, 2025, and carries no small business set-aside designation. This delivery order will be performed at Cepheid's Sunnyvale facility and represents a focused procurement of diagnostic reagents and test kits for rapid detection of three major respiratory pathogens.

This award falls under Cepheid's broader federal contracting relationship with the Department of Defense and Veterans Affairs, where the company has established itself as a primary supplier of point-of-care molecular diagnostic systems. Cepheid holds two significant indefinite delivery contracts with the VA's Veterans Integrated Service Networks valued at over $35 million combined, which serve as the framework for ongoing procurement of diagnostic testing solutions across federal healthcare systems. The current delivery order reflects the continued demand for multiplex respiratory pathogen testing capabilities within the Defense Department's medical supply operations, supporting clinical diagnostics and infectious disease surveillance across the federal health system.